Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines

Abroad (travel likely)RecruitingPHASE3

Conditions

Migraine

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Advocate Christ Medical Center Emergency Department, Oak Lawn, Illinois, United States
Contact: Study coordinator (Samar Ashrafi, PharmD) · samar.ashrafi@aah.org · 708-684-7895

Study leads

Ryan McKillip, MD
Principal Investigator
Wake Forest University Health Sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine

Abroad (travel likely)RecruitingPHASE3

Huntsville, United States · Fayetteville, United States

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

Episodic Migraine

Abroad (travel likely)RecruitingPHASE3

Chandler, United States · Phoenix, United States

The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy

Migraine · Chronic Migraine Headache

Abroad (travel likely)RecruitingPHASE3

Grålum, Norway · Kristiansand, Norway

Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)

Chronic Migraine

Abroad (travel likely)RecruitingPHASE2

Bergen, Norway · Lørenskog, Norway